In the toothless (tl/tl) osteopetrotic rat, teeth form but fail to erupt. Treatment of tl/tl rats with colony-stimulating factor-1 (CSF-1) activates bone resorption by osteoclasts, permits tooth eruption, and upregulates the immunoreactivity of bone marrow mononuclear cells to growth hormone receptor (GHr) and insulinlike growth factor (IGF)-I. This study examined the distribution of tartrate-resistant acid phosphatase (TRAP) and immunoreactivity for GHr and IGF-I in osteoclast-like cells located on the alveolar bone margin, adjacent to the lower first molar crown, in 14-day-old normal and tl/tl rats, following treatment with CSF-1. Osteoclast-like cells demonstrated a positive reaction for TRAP, GHr, and IGF-I in all groups. However, in tl/tl tissue, osteoclast-like cells were generally negative for GHr. There was no significant difference in the total number of TRAP-, GHr-, and IGF-I-positive osteoclast-like cells on the adjacent bone margin in normal, normal treated with CSF-1, and tl/tl rats. CSF-1 treatment of the tl/tl rat significantly increased the total number of osteoclast-like cells, which were positive for TRAP (p < 0.001), GHr (p < 0.05) and IGF-I (p < 0.01).
I. INTRODUCTION
Tooth eruption is a precisely timed, complex process, which requires localized bone resorption to form an eruption pathway (Marks, 1981) and a functioning dental follicle to regulate local bone metabolism (Marks and Cahill, 1987) . Colony-stimulating factor (CSF)-1 is considered to play a role in the complex process of tooth eruption. It has been proposed that CSF-1 enhances local alveolar bone resorption by increasing the number of mononuclear cells in the dental follicle and osteoclasts on adjacent alveolar bone surfaces (Cielinski et al., 1995; Que and Wise, 1997) . Dental follicle cells transcribe and translate CSF-1 (Wise and Lin, 1994; and express receptors for CSF-1 . The peak gene expression of CSF-1 in the follicle of the rat lower first molar, is at day 3 postnatally , coincidental with the timing for the maximum influx of monocytes into the follicle (Wise and Fan, 1989; Cielinski et al., 1994) .
The toothless (tl/tl) rat is an osteopetrotic animal in which osteoclast, macrophage, and mononuclear cell numbers are reduced (Seifert, 1996; Seifert et al., 1988) . In this osteopetrotic animal, teeth form but fail to erupt, and remain embedded within their bony crypts (Iizuka et al., 1992) . The bone defect in this mutation is not Growth Hormone Receptor and Insulin-like Growth Factor-I Immunoreactivity in Osteoclast-like Cells During Tooth Eruption in the Toothless (Osteopetrotic) Rat Following Treatment with Colony-Stimulating Factor-1 cured by bone marrow transplantation (Marks, 1977) but is improved following treatment with CSF-1 (Iizuka et al., 1992; Marks et al., 1993) . CSF-1 treatment of tl/tl rats from birth promotes eruption of incisors and molars, which is delayed compared with normal littermates (Iizuka et al., 1992) .
CSF-1 affects the proliferation, differentiation, and survival of mononuclear phagocyte lineage cells (Stanley et al., 1983) and promotes the formation of osteoclasts from hematopoietic stem cells (Antonioli-Corboz et al., 1992; Tanaka et al., 1993) . Treatment of tl/tl mutants with CSF-1 increases osteoclasts, macrophages, and bone resorption and permits tooth eruption (Iizuka et al., 1992 . In the tibia, we have shown that CSF-1 treatment upregulates the immunoreactivity of bone marrow mononuclear cells (BMMC) to growth hormone receptor (GHr), insulin-like growth factor (IGF)-I, and IGF-I receptor (IGF-Ir), and increases the number of tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts (Symons et al., 1996b; Joseph et al., 1999) . The importance of this CSF-1-responsive bone marrow cell population in osteoclast function and bone resorption remains to be determined. However, enhanced expression of GHr (Zhang et al., 1992; Symons et al., 1996a Symons et al., , 1998 Tengku et al., 2000; Ong et al., 2001) , IGF-I (Symons et al., 1996a (Symons et al., , 1998 , and IGF-Ir (Joseph et al., 1994; Ong et al., 2001) by osteoclasts, on the adjacent alveolar bone, has been observed during tooth eruption and orthodontic tooth movement. Additionally, in vitro studies have implicated a role for GH and IGF-I in osteoclast maturation and bone resorption activity (Fiorelli et al., 1996; Chihara and Sugimoto, 1997; Guicheux et al., 1998; Kanatani et al., 2000) .
At 14 days-of-age, the lower first molar in normal rats is in the eruptive phase, with bone resorption occurring above the erupting tooth to provide an eruption pathway for emergence into the oral cavity. The aim of this study was to take advantage of this predictable, rapid recruitment of osteoclasts, to determine the distribution of TRAP, GHr, and IGF-I in osteoclast-like cells located on alveolar bone margins, adjacent to the lower first molar, in 14-day-old normal and mutant tl/tl rats following treatment with CSF-1.
II. MATERIALS AND METHODS

A. Source and Treatment of Animals
Rats were bred and treated at the University of Massachusetts Medical School. Osteopetrotic mutant animals (tl/tl) were identified radiographically at birth by the failure to develop marrow cavities in long bones (Schneider et al., 1979) . Normal homozygotes (+/+) and heterozygotes (+/tl) are distinguishable only by breeding, and normal littermates included both these genotypes. Animals were maintained and used in accordance with directives of the Guide for the Care and Use of Laboratory Animals, prepared by the Animal Research Committee of the University of Massachusetts Medical School and guidelines from the Institute on Laboratory Animals Resources, National Research Council (DHHS Publ. NIH 86-23, 1985) . Four normal and four mutant rats were treated with highly purified recombinant human CSF-1 (Ladner et al., 1987; Halenbeck et al., 1989) , which was generously provided by Chiron Corporation. Administration of the growth factor was by subcutaneous injection of 10 6 units every 48 hours (Ralph et al., 1986) , beginning at birth for a period of 2 weeks. Four untreated mutants and four normal littermates served as controls.
B. Tissue Preparation
At 14 days-of-age, animals were anesthetized (Nembutal, 35 mg/kg), radiographed, and killed by decapitation. The mandibles were removed, fixed for 4 hours at 4°C in Bouin's solution (1.2% picric acid, 10% formaldehyde, and 5% glacial acetic acid), washed twice in 10% EDTA for 30 minutes, demineralized for 14 days in 10% EDTA at 4°C with two changes, dehydrated in alcohol, and embedded in paraffin under vacuum using standard methods. Transverse sections (5 µm thick) of the lower first molar were mounted on glass slides.
C. Tartrate-Resistant Acid Phosphatase Activity
Tartrate-resistant acid phosphatase (TRAP) activity was demonstrated using napthol ASTRphosphate (in N,N-dimethyl formamide) as a substrate and pararosaniline-HCL as a coupling agent in L(+)-tartric acid, at 37°C for 30 minutes (Minkin, 1982) . Slides were counterstained with 0.2% methyl green solution and mounted. Incubation with no substrate served as a control (Joseph et al., 1999; Ong et al., 2000; Tengku et al., 2000) .
D. Antibody Production
The following antibodies were used:
1. A monoclonal antibody to GHr raised in mice against a human GH affinity purified rat liver GHr (Barnard et al., 1984; 1985) . This antibody has been used to detect the receptor in rat tissue (Lobie et al., 1990; García-Aragón et al., 1992; Zhang et al., 1992; Symons et al., 1994 Symons et al., , 1996a Symons et al., , 1996b Symons et al., , 1998 Tengku 2000; Ong et al., 2001 ). 2. A polyclonal antibody to IGF-I was raised in rabbit against recombinant human IGF-I. This antibody has been shown to cross-react with rat tissues and has been demonstrated to have less than 0.5% cross-reactivity with IGF-II (Breier et al., 1991; Joseph et al., 1993 Joseph et al., , 1999 Ong et al., 2001 ).
E. Immunohistochemistry
Deparaffinized sections were processed for the detection of GHr and IGF-I using a three-layer streptavidin peroxidase technique. Specific techniques for detection of GHr (Symons et al., 1994 (Symons et al., , 1996b (Symons et al., , 1998 Zhang et al., 1992) and IGF-I (Joseph et al., 1993 (Joseph et al., , 1999 in rat tissue have previously been described. Sections were counterstained with Mayer's haematoxylin, dehydrated, mounted, and viewed using a light microscope magnification of 100×. Controls included: (a) omission of the primary antibody; (b) omission of the secondary antiserum; (c) incubation with nonimmune serum; (d) use of rat liver tissue (GHr) and digestive tract (IGF-I) as a positive control.
F. Quantitation of TRAP and Antibody Expression by Osteoclast-like Cells
Multinuclear osteoclast-like cells positive for TRAP, GHr, and IGF-I on the adjacent bone surface surrounding the molar crown were counted at a magnification of 100×. The total number of positive cells was determined and then expressed as the number of positive cells per unit (linear millimeter) of bone surface. The adjacent bone surface was that surface that faced the buccal, occlusal, and lingual aspects of the molar crown and did not include bone surfaces adjacent to developing roots. The length of the adjacent bone margin was determined from photographic records of each section. The adjacent bone margin surface was outlined and a linear measurement (mm) determined. Two sections per animal, per group were used for cell counts, providing 8 sections per stain for each analysis. Arithmetic means and standard deviations were determined for each group. The comparative differences in mean values were tested using a one-way analysis of variance (ANOVA) program (InStat, GraphPad Software Inc., San Diego, CA, USA). Differences were considered significant at the p < 0.05 level.
III. RESULTS
A. Specificity of Immunohistochemical Staining
TRAP activity was not detected in sections where the substrate was omitted. Immunoreactivity was not observed in sections incubated without primary antibody, without the secondary antiserum, and with nonimmune serum. Immunoreactivity was observed only in sections incubated with the test antibodies. Antibody reaction was confirmed by using appropriate tissue sections from the rat, which demonstrate immunoreactivity for the test antibody (Symons et al., 1996a (Symons et al., , 1996b (Symons et al., , 1998 Joseph et al., 1999) .
B. Relationship of the Adjacent Bone to the Occlusal Surface of the First Mandibular Molar
Resorption of bone occlusal to the erupting molar was evident in normal and CSF-1-treated normal rats. In these animals, at 14 days-of-age, no morphological differences were observed in the development of the first molar and its relationship to the adjacent alveolar bone. Alveolar bone was present on the buccal and lingual aspects, and the molar was close to emerging into the oral cavity.
In tl/tl rats, lack of bone resorption prevented expansion of the crypt around the first molar. Alveolar bone adjacent to the developing crown was present on the buccal and lingual, and extended over the lateral aspects of the occlusal surface covering approximately half the occlusal surface. In tl/tl rats treated with CSF-1, bone was present only on the buccal and lingual aspects of the first molar.
C. TRAP Activity and Antibody Immunoreactivity
TRAP-positive staining was located in the cytoplasm of osteoclast-like cells in all groups. Osteoclast-like cells in the tl/tl rat tended to be smaller and stained less intensely for TRAP activity (Fig. 1) . Total cell counts for TRAP activity and immunoreactivity are presented in Table 1 . CSF-1 treatment significantly increased the number of TRAP-positive osteoclast-like cells in the tl/tl rat (p < 0.001). No such effect was observed for normal animals. In all groups studied, many osteoclast-like cells lacked GHr immunoreactivity. GHr-negative osteoclast-like cells tended to be ovoid to columnar in shape and had a smaller zone of contact with bone ( Fig. 2A) . In tl/tl tissue sections, osteoclastlike cells tended to be negative for GHr immunoreactivity. Only the occasional osteoclast-like cell demonstrated very faint staining on the cell membrane adjacent to the bone (Fig. 2B) . In normal and both CSF-1-treated groups, GHr immunoreactivity was observed occasionally in both the cytoplasm and nucleus (Fig. 2C ), on the cell membrane (Fig. 2D) , and more commonly in the cytoplasm (Fig. 2E) .
IGF-I immunoreactivity was present in a small number of osteoclast-like cells in all animal groups examined. Immunoreactivity was observed in the cytoplasm (Fig. 2F ) and in both the cytoplasm and nuclei (Fig. 2G) .
There was no significant difference in the total number of TRAP-, GHr-, and IGF-I-positive osteoclast-like cells on the adjacent bone margin for normal and normal CSF-1-treated animals. CSF-1 treatment significantly increased the total number of TRAP-(p < 0.001), GHr-(p < 0.05), and IGF-I-positive (p < 0.01) osteoclast-like cells in tl/tl animals. Overall relatively few osteoclast-like cells expressed GHr and IGF-I. Cells immunoreactive to GHr were not necessarily immunoreactive to IGF-I.
The length of the bone margin adjacent to the developing crown was determined by resorption forming the eruption pathway and expansion of the crypt to accommodate the developing molar (Table 2) . CSF-1 treatment did not significantly alter the length of the adjacent bone margin in the normal or tl/tl group. Treatment with CSF-1 significantly increased the number of TRAP-(p < 0.001), and GHr-positive (p < 0.05) osteoclast-like cells per linear mm in the tl/tl rat. No significant difference in the number of IGF-Ipositive osteoclast-like cells/mm bone was observed (Table 2) .
IV. DISCUSSION
We used tooth eruption as a model (Marks and Cahill, 1987) to examine the immunoreactivity of osteoclast-like cells to GHr and IGF-I following treatment with exogenous CSF-1. In the normal animal, CSF-1 treatment did not affect the number of positive osteoclast-like cells for TRAP, GHr and IGF-I. CSF-1 treatment significantly increased the number of TRAP-(p < 0.001), GHr-(p < 0.05), and IGF-I-positive (p < 0.01) osteoclast-like cells in the tl/tl rat.
Where the bone resorption necessary for tooth eruption occurred in normal rats, a small percentage of the osteoclast-like cell population demonstrated immunoreactivity to GHr. Variations were noted in the distribution of this immunoreactivity within these cells. Generally, tl/tl rat osteoclastlike cells lacked immunoreactivity for GHr. However, at high magnification, pale staining was observed in the region of the cell approximating the bone surface. Following CSF-1 treatment, osteoclast-like cells in tl/tl tissue sections demon- strated a more intense GHr immunoreactivity in the cytoplasm and occasionally in the nucleus. A positive reaction on the cell membrane was only visible in cells with little or no staining within the cytoplasm and may imply the presence of receptors at this site. IGF-I immunoreactivity was observed in a greater proportion of osteoclast-like cells in all groups studied. Distribution of IGF-I immunoreactivity within the cells was variable but tended to be located in the cytoplasm and occasionally in the nucleus. The cellular morphology of osteoclast-like cells that demonstrated GHr and IGF-I immunoreactivity was similar to that of osteoclasts active in bone resorption. CSF-1 treatment significantly increased the number of TRAP-positive osteoclast-like cells on the adjacent bone margin in the tl/tl rat. Cell counts for TRAP-positive osteoclast-like cells in the experimental groups studied are similar to that previously reported (Cielinski et al., 1995) . In the CSF-1-treated tl/tl rat, intense TRAP activity was present on the buccal and lingual bone margins, in particular, on those margins closest to the oral cavity. As previously reported, reduced TRAP staining was observed in tl/tl tissue sections (Cielinski et al., 1995) .
Bone resorption activity associated with the lower first molar in the tl/tl rat was consistent with that previously reported (Iizuka et al., 1992; Cielinski et al., 1995) . In the tl/tl rat, the molar crown was almost completely surrounded by bone (Iizuka et al., 1992) and little space was present between the bone and developing molar. However, following CSF-1 treatment in the tl/tl rat, expansion of the crypt permitted the molar crown development to progress normally and bone resorption forming an eruption pathway was evident.
GH is a major regulator of postnatal skeletal growth and development (Underwood and Van Wyk, 1992) and regulates growth either directly or through the actions of the mediator IGF-I (Salmon and Daughaday, 1957) . In vivo administration of hGH leads to an activation of osteoclasts and osteoblasts (Vandeweghe et al., 1993; Kassem et al., 1994; Brixen et al., 1995) . It is possible that GH affects osteoclastic bone resorption by directly acting on mature osteoclasts and their precursor cells or by indirectly acting on them via nonosteoclastic cells, such as stromal cells (including osteoblasts) (Nishiyama et al., 1996; Guicheux et al., 1998) . The mechanism of action of GH on bone resorption mediated by stromal cells may be through an increase in IGF-I production and/or activity (Nishiyama et al., 1996; Rousselle et al., 2000) .
The expression of GHr by osteoclast-like cells during tooth eruption and tooth movement (Zhang et al., 1992; Symons et al., 1996a Symons et al., , 1998 Tengku et al., 2000; Ong et al., 2001 ) suggests a role for GH in local alveolar bone resorption necessary for tooth eruption. The present study supports the above proposal, since GHr immunoreactivity was located on the cell membrane in the cytoplasm and nuclear region of osteoclast-like cells whose morphology resembled that of a functioning osteoclast. The variation in location of the GHr immunoreactivity may reflect the processing of the GHr molecule by the individual cell. The almost complete absence of GHr expression in tl/tl osteoclastlike cells may be due to a deficiency in suitable osteoclast precursors, as bone marrow spaces are restricted in these animals and contain few mononuclear cells, and those mononuclear cells that are present lack GHr immunoreactivity (Symons et al., 1996b) . CSF-1 ameliorates the osteopetrotic condition and upregulates the expression of GHr (Symons et al., 1996b) , IGF-I (Joseph et al., 1999) and IGF-Ir (Joseph et al., 1999) , in bone marrow cells in the tl/tl rat. The role of these mononuclear cells in osteoclast formation and function remains to be determined. However, GH is able to stimulate mouse osteoclast-like cell formation from hemopoietic blast cells supported by GM-CSF (Nishiyama et al., 1996) . The PCR product of mouse GHr was detected in these hemopoietic blast cells supported by GM-CSF, indicating a possible mechanism whereby GH may interact with osteoclast precursors and stimulate osteoclast-like cell formation (Nishiyama et al., 1996; Chihara and Sugimoto, 1997) . 0.98 ± 0.14 4.2 ± 1.1 0.4 ± 0.4 2.0 ± 1.8 tl/tl + CSF-1 4 2.11 ± 0.3 8.7 ± 2.0*** 1.6 ± 1.2* 2.6 ± 0.9 * p < 0.05; *** p < 0.001. Note: CSF-1 significantly increased the number of TRAP-and GHr-positive cells/ mm bone in the tl/tl rat.
The expression of IGFs has been demonstrated in preosteoclasts (Fiorelli et al., 1996) and osteoclasts (Middleton et al., 1995) . Similarly, in the present study, IGF-I was expressed in osteoclast-like cells and was located in the cytoplasm and within the nuclear region. Expression of IGF-I, but very limited GHr, by osteoclast-like cells in the tl/tl mutant, is interesting and suggests that local IGF-I production may be partially independent of GH. This is supported by the observation that the bone resorption, necessary for tooth eruption, proceeds normally in GH-deficient rodents (Symons and Seymour, 2000) . The presence of a functionally active specific IGF-Ir on mature osteoclasts supports a role for IGF-I in the activation of mature osteoclasts through the direct stimulation of local transmembrane receptors (Hou et al., 1997; Middleton et al., 1995) . A binding site for IGF-I has been reported on hematopoietic blast cells (Nishiyama et al., 1996) , which implies that IGF-I may directly stimulate the recruitment and formation of osteoclasts. It has been shown that IGF-I supports the activation and formation of osteoclasts and that osteoblasts mediate IGF-I-stimulated formation of osteoclasts (Slootweg et al., 1992; Mochizuki et al., 1992; Hill et al., 1995) .
This study has shown that a number of osteoclast-like cells located in an area where bone resorption occurs during the formation of an eruption pathway are immunoreactive for GHr and IGF-I. Treatment of the tl/tl rat with CSF-1 increased the number of TRAP-, GHr-, and IGF-I-positive osteoclast-like cells on the bone margin adjacent to the crown of the lower first molar concomitant with the restoration of bone resorption. These data support the postulate that in the tl/tl rat, CSF-1 is involved in the stimulation of bone resorption and development of functional osteoclast-like cells that may be immunoreative for GHr and IGF-I. However, as CSF-1 only partially resolves the bone resorption defect in the tl/tl rat (Marks et al., 1993; Sundquist et al., 1995) , other growth factors may be required to normalize osteoclast number and activity.
